港股開市 | 恒指高開1.07%,美團績後高開2.54%,康方生物-B高開2.38%
香港恒生指數開市上升246.10點,升幅1.07%,報23198.34點;恒生國企指數開市上升104.88點,升幅1.11%,報9570.82點;恒生紅籌指數開市上升26.24點,升幅0.72%,報3655.77點。
【藍籌股】
50隻恒指成分股,43隻開升,7隻平開,信和置業高開2.63%,為表現最佳藍籌股。
【個股方面】
美團點評-W高開2.54%,美團點評疫情之下展現韌性,一季度收入下降12.6%至168億元人民幣,淨虧損15.8億元人民幣,均優於分析師預計。
康方生物-B高開2.38%,中國生物製藥高開1.91% ,經典型霍奇金淋巴瘤治療藥物派安普利單抗新藥上市申請獲受理。
騰訊高開1.39%,騰訊將成為日本遊戲開發商Marvelous的第一大股東。
藥明康得高開3.04%,知情人士透露,由藥明康得投資的一家中國製藥商北海康成與摩根士丹利合作,啟動香港IPO早期籌備工作,計劃最快秋季上市,可能籌資至多2.5億美元。
蒙牛乳業高開1.43%, 中金發表研報稱,中國乳品龍頭二季度起有望逐季復蘇,推薦光明乳業、伊利股份和蒙牛乳業。
贛鋒鋰業高開2.24%,中國工信部部長苗圩表示,中國將有序放開新能源汽車代工生產方式,繼續加大充電基礎設施的建設,並鼓勵充電設施實現互聯互通。
免責聲明:本文所載的所有資料、資料等(「資料」)只供參考之用,不構銷售或建議任何投資、交易策略或金融產品的要約或招攬。本公司會盡力確保資料的準確性及可靠性, 但不保證該資料為準確無誤, 亦不承擔因任何不準確或遺漏而引起的損失或損害。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.